The global market for hemodialysis and peritoneal dialysis is one of the most steadily expanding markets in the global healthcare industry. The massive rise in the number of patients suffering from kidney diseases such as chronic kidney failure and the rising number of patients opting for renal replacement therapy are working in favor of the market. Technological advancements, increased awareness regarding available treatments, and increased healthcare expenditure, especially from the patient population across developing economies, are also opening up promising growth opportunities for the global hemodialysis and peritoneal dialysis market.

Besides the rising number of critical-stage kidney disease patients, the rising number of people suffering from chronic conditions such as hypertension and diabetes are also positively influencing the overall development of the global hemodialysis and peritoneal dialysis market. The market is expected to witness a positive rise in venture funding and private investment aimed at the development of new and more improved products, and a massive rise in focus and expenditure from governments across the globe for improving the healthcare infrastructure required for the treatment of critical-stage kidney diseases.

However, certain factors, such as the low rate of awareness about the available treatments for kidney diseases, the high cost of undergoing hemodialysis and peritoneal dialysis, which could dissuade cost-conscious patients, especially across developing economies, from adopting such treatments, and the bleak medical reimbursement scenario in several countries could challenge the expansion of the market to a certain extent.

Global Hemodialysis and Peritoneal Dialysis Market: Overview

Hemodialysis refers to the treatment wherein a complex set of tubes is used to take out blood from the body, and then run through a filter known as dialyzer. The impurities in the blood are removed and the blood is redirected into the patient’s body. This procedure is typically performed three to four times a week in dialysis centers across different commercial and medical facilities.

Peritoneal dialysis (PD) is perhaps the simplest form of dialysis, which can be performed with minimum lifestyle changes and high degree of freedom. In this method, the exchange of dialysis fluid can be done through a synthetic tube which is placed in the abdominal cavity.

GET BROCHURE OF THE REPORT

Global Hemodialysis and Peritoneal Dialysis Market: Key Trends

The increasing incidence of end stage renal disease (ESRD), diabetes, and hypertension, lower patient preference for kidney transplants, along with technological advancement in the field of hemodialysis and peritoneal dialysis have been the major growth drivers of the market. As peritoneal dialysis offers benefits such as minimal interference with lifestyle and routine, personalized treatment for individual needs of patients, and can be performed at home, and even while the patient is asleep, thus saving significant amount of time, numerous patients with responsibilities and active lifestyles have been opting for this form of maintenance dialysis.

On the other hand, growth of this market might be inhibited as this procedure needs to be performed every single day and also increases the risk of peritonitis (infection of the membrane that lines the abdomen). However, significant growth opportunities might crop up as increasing investments are directed toward product development.

Global Hemodialysis and Peritoneal Dialysis Market: Market Potential

The global market for hemodialysis and peritoneal dialysis has been witnessing considerable number of new product launches and product approvals. For instance, in March 2017, Humacyte received the first Regenerative Medicine Advanced Therapy (RMAT) Designation for its investigational treatment called Humacyl, by the US Food and Drug Administration (FDA). Similarly, during the same month, NxStage Medical Inc.’s System One, a next-gen hemodialysis system received the CE mark in Europe. The system features new capabilities such as integrated blood pressure monitor and a touchscreen user interface.

Another authorization by the European Commission (EC) was granted for Amgen’s Parsabiv, a new calcimimetic agent administered to adult patients suffering from chronic kidney disease (CKD) who are undergoing hemodialysis.

GET TABLE OF CONTENT OF THE REPORT

Global Hemodialysis and Peritoneal Dialysis Market: Regional Outlook North America is likely to dominate the global market for hemodialysis and peritoneal dialysis over the forecast period. According to the findings of U.S. Department of Health and Human Services, nearly 47,000 Americans lost their lives to kidney disease in 2013. The overall incidence of chronic kidney disease was found to be around 14%. As a result, the demand for peritoneal dialysis and hemodialysis is expected to rise substantially in the U.S. European countries are also slated for significant growth.

Asia Pacific will exhibit maximum growth over the next few years, as the market in this region is driven by growing healthcare expenditures, rising awareness about health, increasing purchasing power of people, and rising incidence of health conditions.

Global Hemodialysis and Peritoneal Dialysis Market: Competitive Analysis

A number of market players have been undertaking mergers and acquisitions, collaborations, and partnerships, apart from expanding their product portfolios. For example, in February 2017, a leading US-based provider of dialysis services, DaVita HealthCare Partners Inc. announced its partnership with Cigna, a healthcare insurance service company on a global scale.

Some of the major companies operating in the global market for hemodialysis and peritoneal dialysis are Nipro Corporation, B. Braun Melsungen AG, Fresenius Medical Care AG & Co. KGaA, NxStage Medical, Inc., DaVita Healthcare Partners, Inc., Diaverum Deutschland GmbH, and Baxter International, Inc.

GET DISCOUNT ON THE LATEST REPORT

TMR Research has rich experience in developing state-of-the-art reports for a wide array of markets and sectors. The brilliance of the experts at TMR Research and their alacrity to conduct thorough research and create phenomenal reports makes TMR Research better than others.

The 5-point growth formula developed by TMR Research provides an insight to the stakeholders and CXOs about the current situation in the market. The growth formula makes the report a perfect companion for the stakeholders and CXOs.

The 5-point growth formula includes the following points:

Along with studying the opportunities necessary for growth, threats are also an important aspect to look upon for the companies and stakeholders in a specific sector. TMR Research studies every negative aspect that will hinder the growth of a specific area of business and includes it in the report. The stakeholders and CXOs will have the benefit of assessing the threat and take the necessary steps to prevent the hindrance caused due to the threats.

Keeping up with the latest trends is crucial in any business or sector. While stakeholders are aware of the trends that are on the surface, TMR Researchers find trends that are deeply entrenched in the particular market or sector. The reports are constantly updated with the latest trends so that the stakeholders and CXOs can derive benefits from the trends and generate good revenues.

Demography forms an important part of the growth pattern of all the markets. Diving deep into the demographics enables maximum output from specific areas. The TMR Research team assesses every region and picks out the vital points that have a large impact on the growth of a market.

The analysts at TMR Research conduct an all-round analysis on the competitive landscape of the market. The observations recorded by the analysts are added to the reports so that every stakeholder gets a glimpse of the competitive scenario and frame their business plans according to the situation.

The COVID-19 outbreak has changed the growth projections of numerous sectors and businesses. The analysts at TMR Research have conducted a conscientious survey on the markets after the pandemic struck. The analysts have put forth their brilliant and well-researched opinions in the report. The opinions will help the stakeholders to plan their strategy accordingly.

The reports offer answers to the top 7 questions that revolve around the growth of the market

Most Trending, TMR Research Reports –

U.S. Clinical Oncology Next Generation Sequencing (NGS) Market

Next-generation Sequencing Data Analysis Market

Herpes Simplex Virus (HSV) Vaccines Market

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Rohit Bhisey TMR Research, 3739 Balboa St # 1097, San Francisco, CA 94121 United States Tel: +1-415-520-1050 Visit Site: https://www.tmrresearch.com/

© 1985 - 2022 BioSpace.com. All rights reserved. Powered by Madgex Job Board Software